THE ROLE OF CHEMOTHERAPY IN DIFFUSE AGGRESSIVE LYMPHOMAS

被引：0
|
作者：
DEVITA, VT [1 ]
HUBBARD, SM [1 ]
YOUNG, RC [1 ]
LONGO, DL [1 ]
机构：
[1] NCI, DIV CANC TREATMENT, BETHESDA, MD 20892 USA
来源：
SEMINARS IN HEMATOLOGY | 1988年 / 25卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2 / 10
页数：9
相关论文
共 50 条
  • [41] Role of Maintenance Therapy after High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation in Aggressive Lymphomas: A Systematic Review
    Taverna, Josephine A.
    Yun, Seongseok
    Jonnadula, Jayasree
    Saleh, Ahlam
    Bin Riaz, Irbaz
    Abraham, Ivo
    Yeager, Andrew M.
    Persky, Daniel O.
    McBride, Ali
    Haldar, Subrata
    Anwer, Faiz
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (07) : 1182 - 1196
  • [42] CHEMOTHERAPY OF DIFFUSE LARGE CELL LYMPHOMAS (DLCL) WITH HIGH-DOSE ADRIAMYCIN
    REEVES, JA
    WHEELER, RH
    LOBUGLIO, AF
    ZUCKERMAN, KS
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 210 - 210
  • [43] Conservative management in primary genital lymphomas: The role of chemotherapy
    Signorelli, Mauro
    Maneo, Andrea
    Cammarota, Sabrina
    Isimbaldi, Giuseppe
    Parra, Rita Garcia
    Perego, Patrizia
    Pogliani, Enrico Maria
    Mangioni, Costantino
    GYNECOLOGIC ONCOLOGY, 2007, 104 (02) : 416 - 421
  • [44] IMMUNOLOGICAL PHENOTYPES OF DIFFUSE, AGGRESSIVE, NON-HODGKINS LYMPHOMAS - CORRELATION WITH CLINICAL-FEATURES
    COSSMAN, J
    JAFFE, ES
    FISHER, RI
    CANCER, 1984, 54 (07) : 1310 - 1317
  • [45] Non-hodgkin's lymphoma in the elderly - Part 2: Treatment of diffuse aggressive lymphomas
    Morrison, Vicki A.
    ONCOLOGY-NEW YORK, 2007, 21 (10): : 1191 - 1198
  • [46] BETA-2 MICROGLOBULIN - A PROGNOSTIC FACTOR IN DIFFUSE AGGRESSIVE NON-HODGKIN LYMPHOMAS
    JOHNSON, PWM
    WHELAN, J
    LONGHURST, S
    STEPNIEWSKA, K
    MATTHEWS, J
    AMESS, J
    NORTON, A
    ROHATINER, AZS
    LISTER, TA
    BRITISH JOURNAL OF CANCER, 1993, 67 (04) : 792 - 797
  • [47] Prognostic implications of ploidy and proliferative activity in the diffuse, aggressive non-Hodgkin's lymphomas
    Winter, JN
    Andersen, J
    Variakojis, D
    Gordon, LI
    Fisher, RI
    Oken, MM
    Neiman, RS
    Jiang, SW
    Bauer, KD
    BLOOD, 1996, 88 (10) : 3919 - 3925
  • [48] Feasibility, toxicity, and activity of LNH84-derived chemotherapy in the management of aggressive lymphomas
    Laurencet, FM
    Zulian, GB
    Bauer, J
    Mermillod, B
    Iten, PA
    Alberto, P
    AMERICAN JOURNAL OF HEMATOLOGY, 1997, 55 (04) : 199 - 204
  • [49] Treatment of Primary Aggressive Gastrointestinal Lymphomas with Intensive Chemotherapy: A 14-Year Experience
    Zvonkov, Eugene E.
    Gabeeva, Nelly G.
    Morozova, Anna K.
    Gavrilina, Olga A.
    Sidorova, Anna A.
    Koroleva, Daria A.
    Obukhova, Tatiana N.
    Kovrigina, Alla
    Parovichnikova, Elena N.
    Savchenko, Valery G.
    BLOOD, 2016, 128 (22)
  • [50] VB-CHEP chemotherapy regimen for aggressive non-Hodgkin's lymphomas
    Yalcin, S
    Kars, A
    Ozisik, Y
    Tekuzman, G
    Özyilkan, Ö
    Celik, I
    Barista, I
    Güllü, I
    Güler, N
    Baltali, E
    Firat, D
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1998, 61 (04) : 261 - 265
12345